XII Medical, a pioneering company dedicated to revolutionizing the treatment of obstructive sleep apnea (OSA) through minimally invasive technologies, has successfully secured $45 million in its latest funding round. This significant investment, led by a consortium of prominent healthcare venture capitalists, will enable XII Medical to further its mission of providing innovative solutions that enhance patient outcomes while minimizing the invasiveness of traditional surgical methods. The company is at the forefront of developing advanced therapeutic options that align with the growing need for effective, patient-friendly treatments for OSA, a condition affecting millions globally. The funding will primarily be allocated towards clinical trials aimed at evaluating the efficacy and safety of their cutting-edge procedures. With this financial backing, XII Medical is poised to accelerate its research and development initiatives, expand its product pipeline, and bring its transformative technologies to market faster than ever before. As the prevalence of sleep apnea continues to rise, the urgency for effective interventions becomes even greater. XII Medical’s groundbreaking approach not only promises to alleviate the burden of this sleep-disordered breathing condition, but also aims to improve overall quality of life for countless patients. The leadership team, fueled by a passion for innovation and patient care, is excited about the new possibilities that this funding presents, and looks forward to making a substantial impact in the field of sleep medicine. With this new phase of growth, XII Medical is on track to redefine standard care practices and ensure that effective treatment for obstructive sleep apnea is accessible to all those in need.

XII Medical Secures $45M in Series B Funding to Advance Minimally Invasive Tech for Sleep Apnea Treatment
Get the full XII Medical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Falaê!
? Falaê | O primeiro ecossistema de gestão da experiência do cliente do Brasil, especialista em bares e restaurantes. No Falaê, ajudamos operações da gastronomia a deixarem o “achismo” de lado e passarem a tomar decisões baseadas em dados reais e estratégicos. A partir de avaliações inteligentes e multi-canais, fornecemos insights valiosos sobre o comportamento, satisfação e experiência dos clientes em cada ponto de contato com o restaurante. Somos mais que uma plataforma de pesquisa. Somos o primeiro ecossistema completo e automatizado de gestão da experiência do cliente voltado exclusivamente para o setor de food service. ? Com o Falaê, o restaurante: ✔️ Coleta feedbacks em tempo real via QR Code, WhatsApp, Tablet e outros canais ✔️ Monitora a jornada do cliente de ponta a ponta ✔️ Acompanha indicadores estratégicos como NPS, CSAT e satisfação por etapa ✔️ Fideliza clientes com base em relacionamento personalizado ✔️ Melhora processos operacionais com ações sugeridas por IA ✔️ Avalia o desempenho da equipe com base na percepção dos clientes ? Transformamos avaliações em inteligência e dados em decisões estratégicas. Nossa missão é empoderar gestores com informações práticas para melhorar o atendimento, aumentar a recorrência e garantir o crescimento sustentável do negócio. Pensou em ouvir o seu cliente? Falaê!
$300.0K Seed
today

Patronus Group
Our mission is to empower older adults to live healthy, connected, and independently by providing easy-to-use health and social technology to create a world where aging is delightful.
$13.0M Unknown
today

auryx
auryx is on a mission to create the world’s best foundation model for turning sound into health insights. Currently, we use machine learning to turn regular existing earbuds into health and fitness sensors, tracking heart rate, HRV, respiration, and advanced cardiovascular parameters, all through devices you already own.
$2.0M Pre-seed
today

Techcyte
Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that improve the efficiency and accuracy of diagnostic testing. Our mission is to positively impact the health of humans, animals, and the environment through the use of artificial intelligence. We do that by partnering with best-in-class labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers. Together, we aim to deliver a unified clinical and anatomic pathology platform to labs and clinics around the world.
$15.0M Unknown
today

strIQ
strIQ is the smarter way to invest in short-term rentals. We built the platform we wished existed — one place to find, evaluate, and acquire STR properties with confidence. ??? ??????? Investors spend hours across Zillow, AirDNA, spreadsheets, and Airbnb listings trying to figure out if a property will actually cash flow. At the end of all that research, they're still guessing. Nobody should spend $300K on a hope and a prayer. ??? ???????? strIQ brings all the data together in one platform: → Find high-potential properties in minutes, not hours → See real comps and what top 10% performers do differently → Underwrite deals with 50th, 75th, and 90th percentile revenue projections → Generate professional pro formas to share with partners and lenders ??? ?? ????? Serious STR investors with $50-500K to deploy who want confidence — not just information — before making a major investment decision. ??? ????????? 85+ investors learning together in our free community. Weekly trainings. Live deal breakdowns. No pitch. No course. Just investors helping investors. ? Join free: http://www.skool.com/striqsquad Founded by Matt Sanderson — 12-year real estate broker, owner of 4 STR properties, and someone who got tired of 27 browser tabs.
$1.0M Seed
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Kimbal India | Series b | $22.0M | 1d ago |
| 2 | ![]() Membrane Technology and Research (MTR) , Inc United States | Series b | $27.0M | 2d ago |
| 3 | ![]() Malta Inc United States | Series b | $60.0M | 3d ago |
| 4 | ![]() SPREAD AI Germany | Series b | $30.0M | 3d ago |
| 5 | ![]() Actively AI United States | Series b | $45.0M | 3d ago |

%20%2C%20Inc.png&w=3840&q=75)


